Product Information

GEMFIBROZIL 600 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1045 per EA under NDC 72603020601. Its NADAC has been published 99 times since Oct 2, 2024.

FDA first approved this application on Sep 16, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GEMFIBROZIL 600 MG TABLET

Gemfibrozil
$0.1045per EA

Strength

600 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603020601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GEMFIBROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA202726

FDA Approved

9/16/2015

TE Code

AB

On Market Since

9/16/2015

Pharmacological Classes

PPAR alpha
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists

Price Statistics

The NADAC for GEMFIBROZIL 600 MG TABLET has been published 99 times since Oct 2, 2024, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1045 per EA
All-time high$0.1096 (Oct 16, 2024)
All-time low$0.0871 (Nov 20, 2024)
52-week high$0.1045
52-week low$0.1005
Median price$0.1036
Average price$0.1029
Largest weekly change-17.1% (Nov 20, 2024)
Weeks tracked99
Tracking sinceOct 2, 2024

Price History

1W

+0.1%

1M

+0.1%

3M

+0.8%

6M

+4.0%

1Y

+0.8%

3Y

N/A

5Y

N/A

All

-4.6%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GEMFIBROZIL 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GEMFIBROZIL 600 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1045 per EA (NDC 72603020601), effective Aug 19, 2026.

How has the price of GEMFIBROZIL 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for GEMFIBROZIL 600 MG TABLET has declined 4.6%. It has been tracked across 99 weekly CMS publications since Oct 2, 2024.

What are the highest and lowest recorded NADAC prices for GEMFIBROZIL 600 MG TABLET?

Since Oct 2, 2024, the NADAC for GEMFIBROZIL 600 MG TABLET has ranged from a low of $0.0871 (Nov 20, 2024) to a high of $0.1096 (Oct 16, 2024), with a median of $0.1036 per EA.

Are there cheaper alternatives to GEMFIBROZIL 600 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GEMFIBROZIL 600 MG TABLET, is $0.0891 per EA — about 15% below GEMFIBROZIL 600 MG TABLET.

Who manufactures GEMFIBROZIL 600 MG TABLET?

GEMFIBROZIL 600 MG TABLET (NDC 72603020601) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.